The innovation conference “Keys to the new health system”, organized by the Institute for the Development and Integration of Health Care (IDIS Foundation), in collaboration with Farmindustria and Fenin, showed that innovation in health technology is the key to the country’s economic development and the sustainability of the health system.
In this sense, it was pointed out that stimulus plans seem to anticipate new models of public-private collaboration, collaborative environments in which the role of the health technology industry will be increasingly relevant as a dynamic agent of innovation and as a strategic ally of the system and of health professionals.
Learn more about the importance of innovation in the healthcare system and find the latest business headlines of the day with the Born2Invest mobile application.
Innovation in healthcare technology
“Covid-19 has put accessibility to the health system under control. Innovation in health technologies is a real catalyst to be able to treat more patients and is essential for the economic development of the country and the development of the health system ”, explained Maria Vila, vice president of Medtronic Spain and Portugal.
In addition, she ensured that we must invest in health technology. “We have had the news of the Inveat Plan with 800 million for the renewal of high-tech equipment, but we still have a long way to go.” He also clarified that the Inveat Plan is limited to certain equipment. “It’s not all about buying hardware, sometimes we need digital solutions,” he said.
Lluís Blanch, coordinator of the Itemas network, emphasized the contribution to innovation of the “forgotten people”, hospitals, where there is talent, money and patients. “Hospitals have already had innovation units for seven or eight years. Whether they are permeable to the entire hospital depends on who is responsible in the hospitals (managers and directors). If we get them interested in innovation, these units will continue to be there, ”he explained.
For her part, María Elena Hernando, professor at the Universidad Politécnica de Madrid (UPM), gave her point of view from the academic sphere on the work of innovation training and advocated the retention of talent. “The culture of innovation must start to come out of schools. When our students go to the hospital, they come with an open mind and are able to think of solutions. As for biomedical engineering, he stressed that its role is fundamental. “We cannot experience progress without technology helping us to diagnose and optimize time.
During this second round table moderated by Margarita Alfonsel, general secretary of Fenin, the existing barriers in the field of innovation were highlighted. The first of these is the quality of the data. “Today in hospitals there is no interoperability in the data, they do not communicate and it is really problematic. A lot of work needs to be done with industry to make data interoperable, ”said the coordinator of the Itemas network. He also identified a second obstacle: the lack of competitiveness. For this reason, he called for “more subsidies for start-ups”, because he considers it important for them to be on the territory, to take root and to be competitive.
Lluís Blanch identified two obstacles to innovation in health technologies: the lack of data interoperability and the lack of competitiveness.
The future role of health technology
For Professor UPM, the future challenge for healthcare technologies is to collect patient data in the least invasive way possible, involve the patient and achieve shared decision-making. “I expect a huge boost to this joint innovation from universities, hospitals and industry.” The speakers also underlined the importance of selling this innovation, of creating wealth and of being able to measure the return.
Ángel de Benito, Secretary General of the IDIS Foundation, closed the conference by stressing that “results in health and care depend on the degree of innovation that we are able to bring to the health system”. Finally, he assured that the engine of the new model of health care must always be a close public-private collaboration.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or associates. Please see our disclaimer for more information.
This article may contain forward-looking statements. These forward-looking statements are generally identified by the words “believe”, “plan”, “estimate”, “become”, “plan”, “” ”and similar expressions. These forward-looking statements involve known and unknown risks and uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from forward-looking statements, which reflect the views of the management of the Company only as of the date hereof. Additionally, be sure to read these important disclosures.
First published in iSanidad, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we have made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this site. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for any losses caused by such reliance on the accuracy or reliability of the translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.